Generic drug
Triazolam price, strengths & recalls
Pharmacies pay $9.97 for 30 tablets of Triazolam 0.25 mg tablet this week, and from $8.40 to $9.97 across its 2 priced strengths and forms. 8 manufacturers make it. Its official label last changed on August 30, 2024.
Generic- Fair cash price
- $21.97
- Strengths
- 2
- Makers
- 8
- Updated
- Nov 11
Triazolam price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 0.125 mg tablet | $0.2799 | $8.40 / 30 tablets |
| 0.25 mg tablet | $0.3325 | $9.97 / 30 tablets |
Supply status: shortages & recalls
What people paid for Triazolam
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use TRIAZOLAM TABLETS safely and effectively. See full prescribing information for TRIAZOLAM TABLETS. TRIAZOLAM tablets, for oral use, CIVInitial U.S. Approval: 1982
WARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE, MISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL REACTIONS
Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of these drugs in patients for whom alternative treatment options are inadequate. Limit dosages and durations to the minimum required. Follow patients for signs and symptoms of respiratory depression and sedation [see Warnings and Precautions (5.1), Drug Interactions (7.1)].
The use of benzodiazepines, including triazolam, exposes users to risks of abuse, misuse, and addiction, which can lead to overdose or death. Abuse and misuse of benzodiazepines commonly involve concomitant use of other medications, alcohol, and/or illicit substances, which is associated with an increased frequency of serious adverse outcomes. Before prescribing triazolam and throughout treatment, assess each patient's risk for abuse, misuse, and addiction [see Warnings and Precautions (5.2)].
The continued use of benzodiazepines, including triazolam, may lead to clinically significant physical dependence. The risks of dependence and withdrawal increase with longer treatment duration and higher daily dose. Abrupt discontinuation or rapid dosage reduction of triazolam after continued use may precipitate acute withdrawal reactions, which can be life-threatening. To reduce the risk of withdrawal reactions, use a gradual taper to discontinue triazolam or reduce the dosage [see Dosage and Administration (2.3), Warnings and Precautions (5.3)].
WARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE, MISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL REACTIONS
See full prescribing information for complete boxed warning.
Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of these drugs in patients for whom alternative treatment options are inadequate. Limit dosages and durations to the minimum required. Follow patients for signs and symptoms of respiratory depression and sedation (5.1, 7.1).
The use of benzodiazepines, including triazolam, exposes users to risks of abuse, misuse, and addiction, which can lead to overdose or death. Before prescribing triazolam and throughout treatment, assess each patient's risk for abuse, misuse, and addiction (5.2).
Abrupt discontinuation or rapid dosage reduction of triazolam after continued use may precipitate acute withdrawal reactions, which can be life-threatening. To reduce the risk of withdrawal reactions, use a gradual taper to discontinue triazolam or reduce the dosage (2.3, 5.3).
Recent major changes (as listed on the label)
Boxed Warning 2/2021
Dosage and Administration (2.3) 2/2021
Warnings and Precautions (5.2, 5.3) 2/2021
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA017892 · Pfizer
- First approved
- November 15, 1982 (44 years ago)
- Latest approved change
- January 13, 2023
- Approved label
- PDF, Jan 17, 2023
- Generic makers
- 2 approved generic applications on the market
Triazolam questions
How much does triazolam cost without insurance?
Pharmacies pay about $9.97 for 30 tablets of triazolam 0.25 mg tablet ($0.3325 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $21.97. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
Is triazolam in shortage?
No shortage is reported for triazolam right now. We check the national shortage list every day.
Has triazolam been recalled?
No recalls are on record for triazolam.
When did the triazolam label last change?
The official label was last updated on August 30, 2024 (version 103). See what changed.
Talk about triazolam
No comments yet. Questions, tips, what worked for you - start the conversation.